IID00525
Uniprot O14920
Protein Inhibitor of nuclear factor kappa-B kinase subunit beta
Gene IKBKB
Organism Homo sapiens
Sequence
LLPS
Network
xml
rdf
Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
756
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Region 4e3c A 11-15 disorder
Region 4e3c A 16-286 order
Region 4e3c A 287-289 disorder
Region 4e3c A 290-373 order
Region 4e3c A 374-382 disorder
Region 4e3c A 383-394 order
Region 4e3c A 395-400 disorder
Region 4e3c A 401-550 order
Region 4e3c A 551-558 disorder
Region 4e3c A 559-665 order
Region 4e3c A 666-669 disorder
Region 4e3c F 11-15 disorder
Region 4e3c F 16-286 order
Region 4e3c F 287-289 disorder
Region 4e3c F 290-373 order
Region 4e3c F 374-382 disorder
Region 4e3c F 383-394 order
Region 4e3c F 395-400 disorder
Region 4e3c F 401-550 order
Region 4e3c F 551-558 disorder
Region 4e3c F 559-665 order
Region 4e3c F 666-669 disorder
Region 4e3c B 11-15 disorder
Region 4e3c B 16-286 order
Region 4e3c B 287-289 disorder
Region 4e3c B 290-373 order
Region 4e3c B 374-382 disorder
Region 4e3c B 383-394 order
Region 4e3c B 395-400 disorder
Region 4e3c B 401-665 order
Region 4e3c B 666-669 disorder
Region 4e3c C 11-15 disorder
Region 4e3c C 16-286 order
Region 4e3c C 287-289 disorder
Region 4e3c C 290-373 order
Region 4e3c C 374-382 disorder
Region 4e3c C 383-394 order
Region 4e3c C 395-400 disorder
Region 4e3c C 401-550 order
Region 4e3c C 551-558 disorder
Region 4e3c C 559-665 order
Region 4e3c C 666-669 disorder
Region 4e3c D 11-15 disorder
Region 4e3c D 16-286 order
Region 4e3c D 287-289 disorder
Region 4e3c D 290-373 order
Region 4e3c D 374-382 disorder
Region 4e3c D 383-394 order
Region 4e3c D 395-400 disorder
Region 4e3c D 401-550 order
Region 4e3c D 551-558 disorder
Region 4e3c D 559-665 order
Region 4e3c D 666-669 disorder
Region 4e3c E 11-15 disorder
Region 4e3c E 16-286 order
Region 4e3c E 287-289 disorder
Region 4e3c E 290-373 order
Region 4e3c E 374-382 disorder
Region 4e3c E 383-394 order
Region 4e3c E 395-400 disorder
Region 4e3c E 401-550 order
Region 4e3c E 551-558 disorder
Region 4e3c E 559-665 order
Region 4e3c E 666-669 disorder
Region 4kik A 2-8 disorder
Region 4kik A 24-26 disorder
Region 4kik A 27-84 order
Region 4kik A 85-88 disorder
Region 4kik A 89-169 order
Region 4kik A 170-179 disorder
Region 4kik A 180-372 order
Region 4kik A 373-375 disorder
Region 4kik A 376-400 order
Region 4kik A 401-403 disorder
Region 4kik A 404-501 order
Region 4kik A 502-507 disorder
Region 4kik A 508-550 order
Region 4kik A 551-557 disorder
Region 4kik A 558-663 order
Region 4kik A 664-664 disorder
Region 4kik B 2-173 order
Region 4kik B 174-176 disorder
Region 4kik B 177-372 order
Region 4kik B 373-375 disorder
Region 4kik B 376-550 order
Region 4kik B 551-557 disorder
Region 4kik B 558-663 order
Region 4kik B 664-664 disorder
Seq 701-730 Hetero trimer : IID00526 Complex ,
IID00745 Complex
Region 3brt C 701-730 order
Seq 701-730 Hetero trimer : IID00526 Complex ,
IID00745 Complex
Region 3brt A 701-704 disorder
Region 3brt A 705-730 order
Seq 701-730 Hetero trimer : IID00526 Complex ,
IID00745 Complex
Region 3brt C 701-730 order
Seq 701-730 Hetero trimer : IID00526 Complex ,
IID00745 Complex
Region 3brt A 701-704 disorder
Region 3brt A 705-730 order
Seq 701-745 Hetero tetramer : IID00745 Complex
Region 3brv C 701-701 disorder
Region 3brv C 702-743 order
Region 3brv C 744-745 disorder
Region 3brv A 701-704 disorder
Region 3brv A 705-743 order
Region 3brv A 744-745 disorder
689-689 Phosphoserine; by autocatalysis
692-692 Phosphoserine; by autocatalysis
682-682 Phosphoserine; by autocatalysis
675-675 Phosphoserine; by autocatalysis
697-697 Phosphoserine; by autocatalysis
670-670 Phosphoserine; by autocatalysis
181-181 Phosphoserine; by TBK1
177-177 Phosphoserine; by TBK1 and PKC/PRKCZ
695-695 Phosphoserine; by autocatalysis
750-750 Phosphoserine; by autocatalysis
740-740 Phosphoserine; by autocatalysis
705-705 Phosphoserine; by autocatalysis
733-733 Phosphoserine; by autocatalysis
180-180 (Microbial infection) O-acetylthreonine; by Yersinia YopJ
Prediction
Disorder 1-8,502-506,663-701,730-756
Order 9-501,507-662,702-729
ProS 502-506,699-701,730-743,750-756
Disorder 1-4,6-8,24-26,170-170,172-184,374-374,551-558,664-709,712-712,719-720,722-756
Order 5-5,9-23,27-169,171-171,185-373,375-550,559-663,710-711,713-718,721-721
Function
Function in SwissProt
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE. IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor. Also phosphorylates other substrates including NCOA3, BCL10 and IRS1. Within the nucleus, acts as an adapter protein for NFKBIA degradation in UV-induced NF-kappa-B activation.